Therapeutics: BCR-ABL tyrosine kinase (BCR-ABL); dengue virus envelope protein E (DENV_gp1)

Infectious disease

INDICATION: Dengue fever

Cell culture studies identified dual inhibitors of BCR-ABL and DENV_gp1 that could help

Read the full 165 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE